Murata, Saori, Morio Nakamura, Kai Sugihara, Tetsuya Sakai, Kota Ishioka, Saeko Takahashi, Shinji Sasada, Hiroyuki Yasuda, and Koichi Fukunaga. 2022. “The Change in Neutrophil-to-Lymphocyte Ratio After Initiation of Nivolumab Monotherapy May Be a Strong Marker of Response and Predictor of Prognosis in Advanced Non-Small Cell Lung Carcinoma”. Asian Pacific Journal of Cancer Care 7 (1), 191-96. https://doi.org/10.31557/apjcc.2022.7.1.191-196.